» Articles » PMID: 28205046

Reproductive Factors and Risk of Colorectal Polyps in a Colonoscopy-based Study in Western Washington State

Overview
Specialties Oncology
Public Health
Date 2017 Feb 17
PMID 28205046
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral contraceptives (OC) are associated with a decreased risk of colorectal cancers; however, a recent study reported an increased risk of small colorectal adenomas associated with OC use. To determine if these results were replicable in a different study population, we investigated the relationship between OC use and other reproductive factors and risk of colorectal polyps in a case-control study in western Washington.

Methods: Study participants were 24-79-year-old female enrollees at an integrated health care system in western Washington who were diagnosed as having adenomas (n = 299), serrated polyps (n = 337), both types of polyps (n = 105) or as polyp-free controls (n = 615) through an index colonoscopy and completed a structured interview to collect reproductive history information. Multivariable polytomous logistic regression was used to compare case groups to controls and to each other; odds ratios (OR) and 95% confidence intervals were estimated.

Results: There was no association between OC use, duration of use, or recency of use and the risk of either adenomas or serrated polyps [adjusted OR for OC ever use (95% CI) 0.85 (0.58-1.23) and 0.96 (0.66-1.40), respectively], and associations did not differ by lesion severity within the adenoma or serrated pathways. Further, no associations were observed between other reproductive factors and risk of colorectal polyp subtypes.

Conclusions: Our results suggest that reproductive factors, including OC use, are not associated with early colorectal cancer precursor lesions.

Citing Articles

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin.

Gerges Geagea A, Rizzo M, Jurjus A, Cappello F, Leone A, Tomasello G Oncotarget. 2019; 10(13):1284-1305.

PMID: 30863490 PMC: 6407684. DOI: 10.18632/oncotarget.26641.

References
1.
Charlton B, Giovannucci E, Fuchs C, Chan A, Lee J, Cao Y . A prospective study of oral contraceptive use and colorectal adenomas. Cancer Causes Control. 2016; 27(6):749-57. PMC: 5177026. DOI: 10.1007/s10552-016-0752-3. View

2.
Simon M, Chlebowski R, Wactawski-Wende J, Johnson K, Muskovitz A, Kato I . Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol. 2012; 30(32):3983-90. PMC: 3488271. DOI: 10.1200/JCO.2012.42.7732. View

3.
McKnight B, Cook L, Weiss N . Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol. 1999; 149(11):984-92. DOI: 10.1093/oxfordjournals.aje.a009759. View

4.
Charlton B, Wu K, Zhang X, Giovannucci E, Fuchs C, Missmer S . Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II. Cancer Epidemiol Biomarkers Prev. 2015; 24(8):1214-21. PMC: 4526380. DOI: 10.1158/1055-9965.EPI-15-0172. View

5.
Nichols H, Trentham-Dietz A, Hampton J, Newcomb P . Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev. 2005; 14(5):1212-8. DOI: 10.1158/1055-9965.EPI-04-0845. View